DENVER, Aug. 14 /PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. , an international e-Health, medical information technology company, will present at the Noble Financial Equity Conference to be held August 20-21 at the Charleston Place Hotel in Charleston, South Carolina.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)
On Monday, August 20, at 9:30 a.m., Global Med’s management will give a 25-minute presentation regarding Global Med’s business and discuss its unique value proposition, latest developments, financial performance and prospects. Management will also participate in a question and answer session following the presentation and in one-on-one meetings throughout the day.
The presentation, with streaming video and PowerPoint presentation, will be webcast live and archived on the websites of Global Med (www.globalmedtech.com), and at Noble Financial’s conference website at www.two-007.net. It is recommended that interested parties register at least 15 minutes prior to the start of the presentation to ensure timely access.
About Noble Financial
Noble Financial is a privately-held, full-service capital markets firm driven by what is often overlooked by other firms -- uncovering the value embedded in the orphaned, undiscovered or misunderstood company. The company focuses on converting market inefficiencies into profit opportunities. Noble Financial supports emerging companies through strategic advice, investment banking, market-making, sales and trading, comprehensive equity research, and the development of institutional support. This is Noble Financial’s third equity conference. The company has operated for 23 years and has offices in Florida and New York City.
About Global Med Technologies, Inc.
Global Med Technologies(R), Inc. is an international e-Health medical information technology company providing information management software products and services to the healthcare industry. Its Wyndgate Technologies(R) division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Each year, Wyndgate’s products and services manage more than eight million blood components, representing over 27% of the U.S. blood supply. Wyndgate’s products are also being used in Canada and sub-Saharan Africa, and are being implemented in the Caribbean. Together, the Donor Doc(TM) interactive donor health history questionnaire, SafeTrace(R) donor management system, and the SafeTrace Tx(R) advanced transfusion management system, recently patented, provide Vein-to-Vein(R) tracking from donor collection to patient transfusion.
For more information about Global Med’s products and services, please call 800-WYNDGATE or visit www.globalmedtech.com, www.peoplemed.com and www.wyndgate.com.
This news release may include statements that constitute forward-looking statements, usually containing the words “believe,” “estimate,” “project,” “expects” or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.
Photo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comGlobal Med Technologies, Inc.
CONTACT: Investors, Paul Holm, paulmholm@gmail.com, or H.L. Lanzet, bothfor Global Med, +1-212-888-4570, or Michael I. Ruxin, M.D., Global MedTechnologies, Inc., +1-303-238-2000
